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The energy demands of the brain are high: they account for at least 20% of the body’s energy consumption.
Evolutionary studies indicate that the emergence of higher cognitive functions in humans is associated with
an increased glucose utilization and expression of energy metabolism genes. Functional brain imaging
techniques such as fMRI and PET, which are widely used in human neuroscience studies, detect signals
that monitor energy delivery and use in register with neuronal activity. Recent technological advances in
metabolic studies with cellular resolution have afforded decisive insights into the understanding of the
cellular and molecular bases of the coupling between neuronal activity and energy metabolism and
point at a key role of neuron-astrocyte metabolic interactions. This article reviews some of the most salient
features emerging from recent studies and aims at providing an integration of brain energy metabolism
across resolution scales.1.Why ShouldWeCare about Brain EnergyMetabolism?
Why should we care about brain energy metabolism or, using a
more contemporary term, neuroenergetics? After all, elegant
and pioneering studies conducted by Kety and Sokoloff in vivo
in humans over 60 years ago clearly showed that glucose is
the obligatory energy substrate for the brain, where it is almost
fully oxidized (Allaman and Magistretti, 2013). Further studies
at the whole-organ level have provided some refinements to
this view, such as, for example, the fact that under particular
conditions, such as fasting, uncontrolled diabetes, or maternal
milk diet in newborns, ketone bodies sustain the energetic
requirements of the brain (Magistretti, 1999 and references
therein).
Technological developments over the last two decades
have, however, afforded new insights at the regional, cellular,
and molecular levels into neuroenergetics; these developments
deserve some renewed attention.
At one end of the resolution spectrum, functional brain imaging
techniques have shed new light on the regulation of regional
brain energy metabolism in register with neuronal activity. An
appreciation of the existence of physiological mechanisms that
couple local activity to energy delivery was in fact provided by
Charles Sherrington over a century ago in a seminal article
(Roy and Sherrington, 1890) where he postulated that ‘‘the brain
possesses an intrinsic mechanism by which its vascular supply
can be varied locally in correspondence with local variations of
functional activity.’’
Indeed, the two main functional brain imaging techniques,
positron emission tomography (PET) and functional magnetic
resonance imaging (fMRI), detect signals that are directly related
to energy delivery and use (Logothetis et al., 2001; Raichle, 1983,
1998). For PET, the distribution of tracers labeled with positron-emitting isotopes such as 18F or 15O reveals changes in cerebral
blood flow (CBF) using 15O-labeled water, glucose utilization
with 18F-labeled 2-deoxyglucose (2-DG), and oxygen con-
sumption with 15O2, which are associated with localized brain
activities. For fMRI, the ‘‘contrast agent’’ is endogenous, being
provided by changes in the ratios of oxy- and deoxyhemoglobin
following activity-dependent processes related to blood flow
and volume as well as to metabolic fluxes (Ogawa et al.,
1990a). Thus, both techniques provide signals that are surrogate
markers of neuronal activity produced by mechanisms that
couple neuronal activity to blood flow and metabolism. These
mechanismswill be discussed in further detail belowwith a focus
on their cellular and molecular underpinnings.
Furthermore, through the use of high-field magnetic reso-
nance spectroscopy (MRS), often using stable isotopes such
as 13C and 1H, it has become possible to study metabolic fluxes
in vivo in laboratory animals and humans under physiological
and pathological conditions (Duarte et al., 2012; Shulman and
Rothman, 2001).
At the other end of the resolution spectrum, studies on homo-
geneous preparations of the cellular elements of the brain, in
particular neurons and astrocytes, such as primary cultures or
fluorescence-activated cell sorting (FACS)-purified cells and sin-
gle-cell analyses by transcriptomics (Cahoy et al., 2008; Lovatt
et al., 2007; Zhang et al., 2014) or using nanosensors/fluorescent
analogs (Barros et al., 2013; Chuquet et al., 2010; Jakoby et al.,
2014) for specific metabolites, have provided means to disen-
tangle the relative contributions of each cell type to themetabolic
processes analyzed by PET, fMRI, andMRS. A current challenge
for neuroenergetics is to integrate the various levels of resolution
scales at which data are gathered to provide a coherent view of
brain energy metabolism across resolution scales.Neuron 86, May 20, 2015 ª2015 Elsevier Inc. 883
Figure 1. Schematic Representation of
Glucose Metabolism
Glucose enters cells through glucose transporters
(GLUTs) and is phosphorylated by hexokinase
(HK) to produce glucose-6-phosphate (glucose-
6P). Glucose-6P can be processed through three
main metabolic pathways. First, it can be metab-
olized through glycolysis (i), giving rise to two
molecules of pyruvate and producing ATP and
NADH. Pyruvate can then enter mitochondria,
where it is metabolized through the tricarboxylic
acid cycle and oxidative phosphorylation, pro-
ducing ATP and CO2 while consuming oxygen (iv).
Under hypoxic conditions or depending on the
cellular metabolic profile (see text), pyruvate can
also be reduced to lactate by lactate dehydro-
genase. This lactate can be released in the
extracellular space through monocarboxylate
transporters. The complete oxidation of glucose
produces larger amounts of energy in the form of
ATP in the mitochondria (30–36 ATPs) compared
to glycolysis (2 ATPs). Alternatively, glucose-6P
can be processed through the pentose phosphate
pathway (PPP) (ii), leading to the production of
reducing equivalents in the form of NADPH.
Note that the PPP and glycolysis are linked at
the level of glyceraldehyde-3-phosphate (GA3P)
and fructose-6-phosphate (fructose-6P). NADPH
produced in the PPP is important for defense
against oxidative stress through the metabolism
of the tripeptide glutathione (GSH). GSH is an
electron donor in several reactions, including the
detoxification of ROS (e.g., the reduction of
peroxides [ROOH] by glutathione peroxidase). The
oxidized glutathione (GSSG) formed as a result is recycled back to glutathione by the action of glutathione reductase using NADPH as an electron donor. In
astrocytes, glucose-6P can also be used to store glucosyl units as glycogen (iii). GPI, glucose-6-phosphate isomerase; PFK, phosphofructokinase; fructose-
1,6-P2, fructose-1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; TPI, triose phosphate isomerase; ribulose-5P, ribulose-5-phosphate; ribose-5P,
ribose-5-phosphate; xylulose-5P, xylulose-5-phosphate; TK, transketolase; sedoheptulose-7P, sedoheptulose-7-phosphate; TA, transaldolase; erythrose-4P,
erythrose-4-phosphate.
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kindled interest in neuroenergetics, a largely underestimated
feature of brain energy metabolism has received sustained
attention over the last decade. Indeed, 10% of glucose entering
the brain yields lactate in a metabolic process known as aerobic
glycolysis, which is the production of lactate in the presence
of oxygen (Vaishnavi et al., 2010). In fact, during development,
aerobic glycolysis accounts for up to 30%of brain glucosemeta-
bolism. In the adult brain, aerobic glycolysis becomes restricted
to specific regions, such as the dorsolateral prefrontal cortex, the
superior andmedial frontal gyrus, or the precuneus and posterior
cingulate cortex, where it accounts for up to 25% of glucose
utilization, whereas in other areas, such as the cerebellum, it is
virtually nonexistent (Bauernfeind et al., 2014; Goyal et al.,
2014). At the cellular level, aerobic glycolysis and lactate produc-
tion are metabolic features of astrocytes but are only marginally
expressed in neurons (Be´langer et al., 2011a). We return to this
point below, as this metabolic process is currently being revis-
ited and is providing new insights into its possible role in brain
function.
2. Cellular Specificity of Energy Metabolism
Given the cellular heterogeneity of the brain, it is not surprising
that different cell types have distinctive metabolic profiles.
Such differences have been particularly studied in neurons and
astrocytes, whereas much remains to be elucidated for oligo-884 Neuron 86, May 20, 2015 ª2015 Elsevier Inc.dendrocytes and microglia. As a first, high-level view, one can
say that neurons are predominantly oxidative whereas glycolysis
predominates in astrocytes (Be´langer et al., 2011a; Hyder et al.,
2006; Zhang et al., 2014). As a reminder, an oxidative profile is
characterized by a series of metabolic steps that lead to the
full oxidation of glucose or of its metabolites, such as pyruvate
and lactate, in the mitochondria, resulting in the production of
approximately 30–36 molecules of ATP per glucose molecule
(or 14–17 if the substrates are the three-carbon molecules
lactate or pyruvate), depending on the degree of coupling of
oxidative phosphorylation. This mitochondrial process involves
the tricarboxylic acid (TCA) cycle, an electron transfer in the
respiratory chain, oxygen consumption, and the production of
CO2 and water (Figure 1). For glycolysis, two molecules of ATP
are produced as glucose is processed to pyruvate. Lactate
is also formed by glycolysis: under low oxygen tension, pyruvate
is converted to lactate in a process that regenerates NAD+,
an essential cofactor necessary to sustain a glycolytic flux
(Figure 1) (Allaman and Magistretti, 2013). However, as noted
earlier, through aerobic glycolysis also known as the War-
burg effect (Warburg, 1956), lactate can also be formed in the
presence of physiological oxygen tension for subsequent
extracellular release and transfer to neighboring cells. The
existence of a metabolic profile predominant in each cell type
had already been identified in pioneering neurochemical studies
performed in the 1950s and 1960s by Hyden in individually
Figure 2. Salient Features that Underlie the
Differences in Metabolic Profiles between
Neurons and Astrocytes
No glycogen is stored in neurons, whereas astro-
cytes are the only cells in the brain that store it.
In neurons, reduced expression and activity
of Pfkfb3, a key positive modulator of glycolysis,
contrasts with high levels of expression and
activity in astrocytes. Cell-specific differential
splicing of pyruvate kinase results in the expres-
sion of the PKM1 isoform exclusively in neurons
and of the PKM2 isoform in astrocytes. Activity of
pyruvate dehydrogenase is high in neurons and
low in astrocytes, due to its high degree of phos-
phorylation in the latter cell type. Taken together,
these cell-specific expression and activity profiles
result in a limited capacity of glycolysis and in an
active TCA cycle and oxidative phosphorylation in
neurons, whereas in astrocytes glycolysis is more
active and can be upregulated whereas pyruvate
processing in the TCA cycle is limited. Expression
and activity of the glyoxalase system that can
detoxify cells of methylglyoxal are considerably
higher in astrocytes. For additional details, see
text.
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Hyden showed that CO2 is produced in isolated neurons at a
much higher rate than in astrocytes and that the enzymatic
complement of each cell type was consistent with a predomi-
nance of glycolysis in glial cells and oxidation in neurons
(Hamberger and Hyden, 1963; Hyden and Lange, 1962). Later
studies in primary cultures of each cell type have yielded similar
results (Be´langer et al., 2011a). Elegant functional studies using
acutely isolated and FACS-purified astrocytes have confirmed
the predominantly glycolytic profile of astrocytes (Lovatt et al.,
2007; Zhang et al., 2014). Modeling studies based on in vivo
magnetic resonance spectroscopy analyses corroborate the
distinct and, as we will see later, functionally complementary
profile of neurons and astrocytes (Aubert et al., 2007; Hyder
et al., 2006; Jolivet et al., 2015).
One point that has created some confusion is that astrocytes
are definitely endowed with mitochondria, a cell biological
feature that suggests robust oxidative activity (Lovatt et al.,
2007; Pysh and Khan, 1972). However, the entry of pyruvate
into the TCA cycle is a regulated process, mainly determined
by the activity of the multiunit enzyme pyruvate dehydrogenase
(PDH) (Figure 2). If the activity of PDH is close to saturation under
basal metabolic conditions, then the added pyruvate flux that
would follow increased glucose uptake cannot be processed
through the TCA cycle, thereby diverting pyruvate to lactate
production. The activity of PDH is regulated by phosphorylation
at several phosphorylation sites; when phosphorylated, PDH
activity is decreased. Work by Halim and collaborators has
shown that the degree of phosphorylation of PDH under basal
conditions is high in astrocytes (Halim et al., 2010). Recently,
Zhang et al. have shown that astrocytes express high levels of
the gene encoding pyruvate dehydrogenase kinase 4 (PDK4),
an enzyme that maintains PDH in a phosphorylated, meaning
less active, state (Zhang et al., 2014) (Figure 2). This situation
provides one of the necessary conditions to favor aerobic glycol-ysis, namely the production of lactate in the presence of normal
oxygen tension. Accordingly, the Sokoloff group has shown
that dephosphorylation of PDH by dichloroacetate results in a
marked increase in oxidative use of glucose by astrocytes and
a concomitant decrease in lactate production by these cells
(Itoh et al., 2003).
This set of results highlights the fact that astrocytes have a
limited capacity to upregulate the processing of pyruvate, the
endproduct of glycolysis, by mitochondria when glucose uptake
is stimulated. In a mirror image, experimental evidence has
been provided indicating that neurons cannot upregulate
glycolysis and that they express high oxidative activity. The
groups of Bolan˜os and Moncada have unraveled the molecular
mechanism that underlies the limited capacity of neurons to
upregulate glycolysis (Bolan˜os et al., 2010; Herrero-Mendez
et al., 2009). They showed that the enzyme 6-phosphofructo-
2-kinase/fructose-2,6-bisphosphatase 3 (Pfkfb3), a key posi-
tive modulator of glycolysis in cells, is constantly subject to
proteasomal degradation, whereas in astrocytes this enzyme
is fully active, thus allowing upregulation of glycolysis (Figure 2).
In fact, glucose is mainly processed through the oxidative
branch of the pentose phosphate pathway in neurons, rather
than through glycolysis. This pathway is the main producer
of reducing equivalents in the form of NADPH, which are used
to regenerate reduced glutathione, in this way providing the
principal molecular effector for scavenging reactive oxygen
species (ROS) produced by the marked oxidative activity of
neurons. Accordingly, if proteasome degradation of Pfkfb3 is
blocked in neurons, resulting in a redirection of glucose
processing through glycolysis rather than through the pentose
phosphate pathway, neurons undergo oxidative stress and
apoptotic death (Be´langer et al., 2011b; Herrero-Mendez
et al., 2009). This set of data indicates that glucose is predom-
inantly used in neurons to maintain antioxidant status rather
than for bioenergetic purposes.Neuron 86, May 20, 2015 ª2015 Elsevier Inc. 885
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2014) that produced a transcriptome database of genes ex-
pressed in acutely isolated neurons and astrocytes by RNA
sequencing and alternative splicing analysis has provided
compelling evidence confirming the metabolic complementarity
between these two cell types. In particular, this in-depth analysis
confirms that the pattern of expression and splicing of selected
genes of glucose metabolism confers to astrocytes the ability
to dynamically upregulate glycolysis, whereas neurons are
locked in a steady state of glycolysis. In addition to confirming
the enrichment of Pfkfb3 in astrocytes, Zhang and colleagues
found a cell-specific differential splicing of the enzyme pyruvate
kinase (PK), with the isoform PKM1 exclusively expressed in
neurons and the PKM2 isoform in astrocytes. PK, by promoting
the conversion of phosphoenolpyruvate to pyruvate, is a key
regulator of glycolysis. The PKM2 isoform, which in addition to
astrocytes is also enriched in cells displaying sustained aerobic
glycolysis such as cancer cells (Ward and Thompson, 2012), can
upregulate the glycolytic flux in response to increased energy
demands, whereas PKM1, the form expressed in neurons,
does not have this property. As noted earlier, the work of Zhang
and colleagues has also confirmed the cell-specific enrichment
(greater than 30-fold) in astrocytes of PDK4, the enzyme that
phosphorylates pyruvate dehydrogenase, rendering it less
active. This fact implies that increases in the glycolytic flux in
astrocytes will result in lactate production, because the entry
of pyruvate into the TCA cycle cannot be upregulated (Figure 2).
Overall, this selective expression of glucosemetabolism genes is
configured to drive glucose processing in astrocytes toward
aerobic glycolysis.
Another distinguishing feature exists between astrocytes
and neurons in respect to glycolysis. A byproduct of glycolysis
is methylglyoxal (MG) (Figure 2), a highly reactive dicarbonyl
compound that promotes the formation of advanced glycation
endproducts (AGEs), which are associated with several neuro-
degenerative disorders (see, e.g., Mu¨nch et al., 2012). MG is
detoxified by cells through the glyoxalase system comprising
glyoxalase 1 (Glo-1) and Glo-2. Both enzymes are expressed
at considerably higher levels in astrocytes compared with
neurons. Accordingly, enzymatic activity rates are several-fold
higher in astrocytes, a feature that renders them, unlike neurons,
resistant to MG toxicity and to AGE accumulation (Be´langer
et al., 2011b). These features endow astrocytes with the capacity
to sustain high levels of glycolysis, as they can detoxify MG, and
to protect neurons against MG toxicity (Be´langer et al., 2011b).
Interestingly, upregulating glycolysis in neurons by increasing
the activity of Pfkfb3 results in increased MG levels and MG-
modified proteins (Be´langer et al., 2011b). This set of results
suggests that the limited capacity of neurons (unlike astrocytes)
to upregulate their glycolytic flux may be related to their weaker
ability to detoxify MG.
Altogether, results reviewed in this section converge to indi-
cate that astrocytes and neurons resort to two complementary
metabolic pathways to produce energy from glucose. That is,
neurons predominantly process glucose through the pentose
phosphate pathway to produce the reducing power (NADPH)
necessary to scavenge molecules producing oxidative stress
that results from their high mitochondrial oxidative activity (Fig-886 Neuron 86, May 20, 2015 ª2015 Elsevier Inc.ures 1 and 2). This pathway implies that neurons utilize sub-
strates, such as pyruvate and lactate, downstream of glycolysis
to feed the TCA cycle and the associated oxidative phosphory-
lation to produce ATP (Figure 2). Consistent with this view, an
uncoupling between glycolysis and the TCA cycle has been
reported in neurons (Bouzier-Sore et al., 2006; Selak et al.,
1985). In contrast, astrocytes, although endowed with a certain
degree of oxidative capacity, predominantly process glucose
glycolytically to produce lactate and pyruvate. A metabolic
complementarity thus appears to exist between astrocytes and
neurons whereby glucose, the almost exclusive energy sub-
strate of the brain, is processed differentially by neurons and
astrocytes. These cell-specific metabolic pathways also imply
a transfer of the three-carbon substrates—lactate and to a lesser
extent pyruvate—from astrocytes, where they are produced by
glycolysis, to neurons, where they are oxidized to yield ATP.
3. Energy-Consuming Processes in the Brain
Given the main mechanisms described above that yield energy
in neurons and astrocytes in the form of ATP or reducing power
(NADPH) (Figure 1), it is then necessary to identify the processes
that cost energy and to determine how this energy is delivered.
Various approaches have been enlisted to establish the ‘‘energy
budget’’ of the brain (Attwell and Laughlin, 2001; Harris et al.,
2012; Hyder et al., 2013; Jolivet et al., 2009). As a first
approximation, it appears that neurons consume 75%–80% of
the energy produced whereas the rest is used for glia-based
processes (Harris et al., 2012; Hyder et al., 2013). As far as
neurons are concerned, energy utilization is related to the activity
of ionic pumps that reestablish the electrochemical gradients
dissipated by signaling, namely action potentials and synaptic
potentials. Which of these two signaling processes dominates
energy consumption in neurons has been debated for some
time. In theoretical estimates based on the classical Hodgkin-
Huxley formalism, Laughlin and Attwell proposed a 50:50 contri-
bution of action potentials and synaptic potentials to neuronal
energy consumption in the rat cerebral cortex (Attwell and
Laughlin, 2001). These estimates have been revised on the basis
of elegant experiments by Geiger and colleagues, who demon-
strated that over 80% of the energy in myelinated hippocampal
axons is expended by postsynaptic potentials (Alle et al.,
2009). These researchers demonstrated the existence of consid-
erable energy efficiency in action potential signaling. Indeed,
unlike in unmyelinated giant axons in squid, the temporal overlap
of the openings of voltage-sensitive sodium channels (VSNCs)
and delayed-rectifier potassium channels (DRKCs), the two
principal channels underlying the generation of action potentials,
is minimal in vertebrate myelinated axons. This means that
the positive charges entering through the VSNCs are only mini-
mally short-circuited by the opening of the DRKCs, resulting in
a limited dissipation of the sodium gradients and hence of
the energy-consuming sodium-potassium ATPase (for a com-
mentary, see Magistretti, 2009). Thus, the majority of the energy
used by neurons for signaling appears to be consumed at the
synapse (Harris et al., 2012). Recent evidence confirms this
view by identifying, in addition to postsynaptic potentials, pre-
synaptic vesicle recycling as an additional energy-consuming
process (Rangaraju et al., 2014). This high energy demand at
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cell body, implies that local mechanisms must exist to sense
synaptic activity and provide the energy substrates necessary
to sustain pre- and postsynaptic processes.
4. Neuron-Astrocyte Metabolic Coupling
In the 1970s, the development of the 2-deoxyglucose autoradio-
graphic technique by Sokoloff and colleagues afforded a means
to determine local energy utilization in register with activation of
specific neuronal circuits in several laboratory animal species
(Sokoloff et al., 1977; Sokoloff, 1981). Although the cellular local-
ization of glucose utilization was not possible with this technique,
Sokoloff and colleagues could still conclude that most of the
glucose utilization visualized with 2-DG was localized in syn-
apse-rich regions of the nervous system. An elegant example
of this was provided in experiments in which somatosensory
stimulation was shown to elicit accumulation of the label in
the synapse-rich dorsal horn rather than in the dorsal root
ganglia, where the cell bodies of the sensory neurons are located
(Kadekaro et al., 1985). More recent work, particularly that by
Logothetis and colleagues (Logothetis et al., 2001), indicates
that fMRI signals spatially coincide with electroencephalo-
gram-recorded local field potentials (LFPs), which are electrical
markers of synaptic activity. Thus, evidence from in vitro and
in vivo biochemical and imaging studies converges to indicate
that (1) the major energetic burden of the nervous system is
localized at the synapse and (2) molecular mechanisms must
exist to couple synaptic activity to local energy delivery. Over
the last three decades, evidence has accumulated pointing at
astrocytes as key cells for the coupling between synaptic activity
and energy metabolism.
Astrocytes belong to the general class of macroglia cells
(Kettenmann and Verkhratsky, 2008). They were described
initially by Virchow (Virchow, 1856, 1859), and a role in the ‘‘dis-
tribution of nutrients’’ to the brain parenchyma was proposed by
Golgi and later Andriezen at the turn of the nineteenth century
(Andriezen, 1893; Golgi, 1886). Further cytological studies using
light and electron microscopes have revealed some particular
features that make astrocytes ideally positioned to sense synap-
tic activity and couple it with the delivery of energy substrates
originating from the capillaries. Indeed, astrocytes feature multi-
ple processes that define spherical volumes of cortex approxi-
mately 80–100 mm in diameter (Bushong et al., 2002; Nedergaard
et al., 2003; Sofroniew and Vinters, 2010). One of these
processes, the endfoot, abuts against the capillary wall whereas
several others ensheath synaptic contacts (Figure 3). Essentially,
the entire outer surface of intraparenchymal capillaries is
covered by astrocytic endfeet (Kacem et al., 1998; Simard
et al., 2003), leaving only clefts of 20 nm between endfeet (Ma-
thiisen et al., 2010). Recent evidence suggests that aquaporin
4-enriched astrocytic endfeet may provide a low-resistance
conduit for solute distribution into the interstitium, through either
specific astroglial transporters or through the intercellular cleft
between endfeet (Iliff et al., 2012). From the interstitium, solutes
are then cleared via paravenous drainage into the cerebrospinal
fluid through a sort of intracerebral lymphatic system, the
glymphatic system. On the synaptic side, astrocytic lamellar
processes ensheath synaptic elements. Such ensheathment ofsynapses by the astrocytic process is dynamic and presents
activity-dependent characteristics (Genoud et al., 2006). In
addition to these morphological features, astrocytes express
proteins at strategic sites that confer upon them the capacity
to sense synaptic activity through receptors and reuptake sites,
notably for glutamate, located on the perisynaptic lamellar
processes (Danbolt, 2001; Iadecola and Nedergaard, 2007; Ka-
cem et al., 1998) and to couple this activity with the import of
substrates, notably glucose, from the capillary through glucose
transporters expressed on the endfoot membranes.
Indeed, in 1994, our group described a mechanism, now
known as the astrocyte-neuron lactate shuttle (ANLS), that could
account for the coupling between synaptic activity and energy
delivery (Pellerin and Magistretti, 1994). We showed that gluta-
mate stimulates glucose uptake and lactate production in astro-
cytes (Pellerin and Magistretti, 1994). This glutamate-stimulated
aerobic glycolysis is triggered by the uptake of glutamate (one of
the main functions of astrocytes), which is cotransported with
sodium with a stoichiometry of one glutamate to three sodium
ions, resulting in the disruption of the sodium gradient. This
triggers the activity of the energy-consuming sodium-potassium
ATPase (Na+/K+ ATPase) at the expense of one ATP per turn of
the pump to extrude three sodiums. Glutamate is mainly con-
verted to glutamine by glutamine synthase at the expense of
another ATP. This glutamate-glutamine cycle allows a large
proportion of glutamate to be recycled to neuronal terminals
to replenish the glutamate vesicular pool (Bak et al., 2006;
McKenna, 2007; Stobart and Anderson, 2013), whereas
the remaining glutamate enters the TCA cycle in astrocytes
after conversion to a-ketoglutarate (Bak et al., 2006; McKenna,
2007; Stobart and Anderson, 2013) (Figure 3). Thus, glutamate
uptake and recycling put an energetic burden on astrocytes,
resulting in a decrease in ATP content (Magistretti and Chatton,
2005). This decrease in the energy charge of the cell promotes
glucose uptake and metabolism by disinhibiting key enzymes
of glycolysis, such as hexokinase and phosphofructokinase
(Figure 1). As noted earlier, the glucose taken up via this mech-
anism is processed glycolytically to yield lactate. Through spe-
cific monocarboxylate transporters (MCTs) (Halestrap, 2013;
Pierre and Pellerin, 2005), MCT1 (also present in other glial cells
and endothelial cells) and MCT4 (specific for astrocytes), lactate
is released, to be taken up by MCT2 (selective for neurons) into
neurons and, after conversion to pyruvate, is processed oxida-
tively in mitochondria to produce 14–17 ATPs per lactate mole-
cule (Figure 3).
The ANLSmechanism thus suggests that the uptake of synap-
tically released glutamate into astrocytes and the ensuing in-
crease in intracellular sodium represent a key signal for activated
neurons to import glucose into astrocytes and produce lactate
as an energy substrate. Accordingly, using the whisker-to-barrel
somatosensory pathway as a model system combined with
two-photon analysis allowing cellular resolution, Chuquet et al.
showed that vibrissal stimulation results in an increase in glucose
uptake predominantly in astrocytes (Chuquet et al., 2010). In the
same physiological system, we showed that when the expres-
sion of the astrocytic glutamate transporter GLAST (EAAT1) is
downregulated with antisense oligonucleotides in a single barrel,
the stimulation of the corresponding vibrissa does not result in aNeuron 86, May 20, 2015 ª2015 Elsevier Inc. 887
Figure 3. Schematic Representation of the Astrocyte-Neuron Lactate Shuttle
Glutamate released at the synapse activates glutamatergic receptors (GluRs), a process associated with energy expenditure in neuronal compartments. A large
proportion of the glutamate released at the synapse is taken up by astrocytes via excitatory amino acid transporters (EAATs;more specifically, GLT-1 andGLAST)
using the electrochemical gradient of Na+ as a driving force, with a stoichiometry of one glutamate to three sodium ions. The disrupted Na+ homeostasis is
reestablished by the action of the Na+/K+ ATPase (in particular the a2 subunit; Pellerin andMagistretti, 1997), an ATP-consuming process. Following its uptake by
astrocytes, glutamate is converted to glutamine by the action of glutamine synthetase (GS), also an ATP-consuming process, and shuttled to neurons, where it is
converted back to glutamate by glutaminases (GLSs). The metabolic burden created by glutamate uptake triggers nonoxidative glucose utilization in astrocytes
and glucose uptake from the circulation through the glucose transporter GLUT1 expressed by both capillary endothelial cells and astrocytes. Glycolytically
derived pyruvate is converted to lactate by lactate dehydrogenase 5 (mainly expressed in astrocytes) and shuttled to neurons through monocarboxylate
transporters (mainly MCT1 and MCT4 in astrocytes and MCT2 in neurons). In neurons, lactate can be used as an energy substrate following its conversion to
pyruvate by LDH1 (mainly expressed in neurons). Under basal conditions, neurons can also take up glucose via the neuronal GLUT3. Concomitantly, astrocytes
participate in the recycling of synaptic glutamate via the glutamate-glutamine cycle. For additional details, see text and Pellerin and Magistretti (2012).
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et al., 2001). Similar results were obtained in knockout transgenic
mice in which the expression of the astrocyte-specific glutamate
transporters was impaired (Voutsinos-Porche et al., 2003a,
2003b). These data indicate that astrocytes play a central role
in coupling synaptic activity to glucose uptake through a
mechanism that is mediated by glutamate transporters; lactate
produced through glutamate-stimulated aerobic glycolysis is
delivered to active synapses through MCTs (Nagase et al.,
2014). Very recently it was shown that pharmacological inhibition
of LDH, one of the components of the ANLS (Figure 3), which
results in a reduction of lactate release by astrocytes, markedly
decreases the excitability of neighboring pyramidal cells (Sada
et al, 2015). For a review and discussion of the ANLSmechanism
and aerobic glycolysis, readers are referred to Pellerin and
Magistretti (2012) and Schurr (2014).
An important point to consider in this context is that ANLS is
operative during glutamate-mediated activation. Under baseline
conditions, there is no doubt that glucose transport and glucose888 Neuron 86, May 20, 2015 ª2015 Elsevier Inc.utilization operate in neurons mostly to produce reducing equiv-
alents (Herrero-Mendez et al., 2009). Indeed, neurons express
glucose transporters of the GLUT3 type as well as hexokinase
activity (Mueckler and Thorens, 2013; Zhang et al., 2014).
Furthermore, mitochondrial oxidative activity occurs also in as-
trocytes, as indicated, for example, by the expression of oxida-
tive phosphorylation genes in purified populations of astrocytes
(Cahoy et al., 2008; Lovatt et al., 2007). However, during gluta-
mate-mediated activation, two mechanisms contribute to the
promotion of glucose uptake into astrocytes and the reduction
of its oxidative fate in these cells. First, glutamate uptake into
astrocytes results in acidification of the mitochondrial matrix.
This glutamate-induced mitochondrial matrix acidification dissi-
pates the cytosol-to-mitochondrial matrix pH gradient, resulting
in the decreased capacity of mitochondrial oxidative phosphor-
ylation in astrocytes (Azarias et al., 2011).
Second, Barros and colleagues (Porras et al., 2004) have
shown that glutamatergic activity results in decreased glucose
utilization in neurons, whereas uptake of saccharide into
Figure 4. Contrasting Spatial Domains in the Neocortex within which VIP Neurons and Noradrenergic Fibers Exert Their Glycogenolytic
Action
Vasoactive intestinal peptide neurons promote glycogenolysis in astrocytes. Given the bipolar nature of the VIP neurons, this effect is restricted to cortical
columns. VIP neurons are activated by corticocortical and thalamocortical specific afferents (SAs). The noradrenergic afferent (NA) fibers span horizontally across
cortical domains and hence can metabolically prime a vast expanse of neocortex by promotimg glycogenolysis in astrocytes. For additional details, see text and
Magistretti and Morrison (1988). I–VI refer to cortical layers. W.M., white matter.
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glutamatergic activity, there is a shift of glucose utilization
away fromneuronsand towardastrocytes, suggesting that anen-
ergy substrate other than glucose (i.e., lactate) must be used by
neurons to meet the increased energy requirements associated
with activation. This observation is consistent with the redox
switchmodel between astrocytes and neurons proposed byCer-
da´n et al. (2006). This model suggests that the lactate transfer
from astrocytes to neurons serves the purpose not only of fueling
theneuronal TCAcycle but alsoof providing reducingequivalents
to neurons. Through this exchange, the intracellular compart-
ments of astrocytes and neurons are coupled and the direction-
ality of the lactate transfer is determined by the redox state of
each cell, mostly oxidized in neurons due to the predominance
of oxidative metabolism there, whereas rather reduced in astro-
cytes owing to their high glycolytic activity. Hence, according tothe redox switch model (Cerda´n et al., 2006), the inhibition of
glucose transport (and consequently of glycolysis) induced by
glutamate in neurons creates thermodynamically favorable con-
ditions for the use of lactate as an energy substrate in this cell
type, because these two processes compete for intracellular
NAD+ (Figures 1 and 2).
Although there is considerable support, both theoretical and
experimental, for the existence of an activity-dependent transfer
of lactate between astrocytes and neurons (see preceding para-
graphs), some aspects of the ANLS mechanism have been
challenged on theoretical or modeling grounds (Dienel, 2012;
DiNuzzo et al., 2010; Mangia et al., 2009a; Patel et al., 2014). In
particular, although the ANLSdoes not exclude glucose neuronal
use under basal conditions (see above and Figure 5 in an original
article by Pellerin and Magistretti, 1994), some members of the
neurochemistry community defend the view that glucose, andNeuron 86, May 20, 2015 ª2015 Elsevier Inc. 889
Figure 5. Multiscale Integration of Cellular Events, Metabolic Indices, and BOLD fMRI Signal during Activation
Synaptic activity results in EPSP generation in postsynaptic neurons (1, N) and glutamate-transporter current in astrocytes (1, A) (green circles). The early energy
requirements of neurons are met by lactate oxidation in neuronal mitochondria, resulting in decreased extracellular lactate levels (2) and oxygen concentration
(2) (red circles). As illustrated by combined PET measurements of glucose utilization, blood flow, and oxygen consumption, an uncoupling between CMRGlu, CBF,
andCMRO2 occurs, resulting in a decreased oxygen extraction fraction (OEF) and increased lactate production (3); the ANLSmodel provides ametabolic context for
these observations with an increased glucose uptake into astrocytes (3) that is processed through aerobic glycolysis, resulting in the replenishment of the extra-
cellular lactate pool (3) (blue circles). A direct glucose uptake by neurons under basal conditions and a potential lactate overflow into the circulation during activation
may occur (dotted arrows). The delayed transient aerobic glycolysis occurring in astrocytes, which does not require an increase in oxygen consumption
commensurate with glucose utilization, results in excess oxyhemoglobin in the activated area, producing the positive BOLD signal (4) (gold circle). The initial dip, or
negative BOLD signal, corresponds to oxygen utilization, resulting in increased deoxyhemoglobin, which occurs during the early phase of synaptic activity (4).CBF:
cerebral blood flow; CMRGlu: cerebral metabolic rate of glucose; CMRO2: cerebral metabolic rate of oxygen; EPSP: excitatory postsynaptic potential.
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in neurons (Dienel, 2012; Hertz et al., 2007). Such an opinion is
mainly based on the grounds of modeling studies suggesting
that the glucose transport capacity is larger in neurons than in as-
trocytes (see DiNuzzo et al., 2010;Mangia et al., 2009b; Simpson
et al., 2007), a prediction considered to be inconsistent with the
ANLS. Such a view is notably based on the determination, using
cytochalasin B binding, of glucose-transporter density in
cultured neurons (Simpson et al., 2007). However, glucose utili-
zation is mainly determined by rate-limiting steps such as, for
example, phosphorylation by hexokinase, implying that glucose
metabolism cannot be reduced to the sole determination of the
amount of transporters (Barros et al., 2007). Essentially it is not890 Neuron 86, May 20, 2015 ª2015 Elsevier Inc.justifiable to derive quantitative in vivo properties of glucose uti-
lization by determining transport capacity, particularly when
considered as a rate-limiting step, from transporter density (for
a discussion of these points, see Jolivet et al., 2010). Further
stressing the importance of glucose uptake into astrocytes
compared with neurons, experiments in transgenic mice pre-
senting a haploinsufficiency of glucose transporters have shown
that decreased expression of the neuron-specific glucose trans-
porter GLUT3 does not result in a pathological phenotype and
does not affect cerebral glucose utilization (Schmidt et al.,
2008; Stuart et al., 2011). In contrast, haploinsufficiency of
GLUT1, which is absent in neurons and expressed in astrocytes,
results in a severe neurological phenotype (Wang et al., 2006).
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substrate for neurons (Dienel, 2012; Hertz et al., 2007, and refer-
ences therein) and that neurons are able to increase their glucose
utilization rate in different conditions (see, e.g., Dienel, 2012; Patel
et al., 2014). The latter interpretation has been discounted rather
convincingly by experimental evidence provided by several
groups reviewed in the preceding paragraphs (Cerda´n et al.,
2006; Herrero-Mendez et al., 2009; Porras et al., 2004). The value
of lactate as an energy substrate is obviously linked to proper ox-
ygen tension in the tissue as, after its conversion to pyruvate, the
metabolic conditions must allow its processing through the TCA
cycle and the associated oxygen phosphorylation. Not surpris-
ingly, a study by Ivanov et al. has shown that in vitro, a condition
used in the studies challenging the value of lactate as an energy
substrate, the energetic role of lactate critically depends on oxy-
gen tension inbrain slicesand that under appropriateoxygenation
conditions lactate sustains oxidative activity even more than
glucose (Ivanov et al., 2011). In fact, the capacity of lactate to sus-
tain neuronal activity was already reported over 60 years ago by
McIlwain (McIlwain, 1953) and later confirmed by various authors
(e.g., Izumi et al., 1997; Schurr et al., 1988). A more detailed dis-
cussion of the arguments that challenge some aspects of the
ANLS on the basis of in vitro and modeling studies has been pro-
vided (Pellerin and Magistretti, 2012).
The temporal sequence by which the ANLS becomes opera-
tive deserves some attention. Indeed, as will be reviewed later
in the discussion on the cellular determinants of the signals
detected by functional brain imaging techniques, in vivo optical
imaging methods have demonstrated the existence of an oxida-
tive metabolism in the early phases of synaptic activity (Malonek
and Grinvald, 1996); these observations are consistent with the
presence of an ‘‘initial dip’’ in the fMRI BOLD (blood-oxygen-
level-dependent) signal, corresponding to decreased deoxyhe-
moglobin concentrations (Hu and Yacoub, 2012, and references
therein), meaning a transient increase in oxygen consumption.
In vitro studies in slices have also indicated a rapid and transient
increase in oxygen consumption concomitant with synaptic
activity (Hall et al., 2012). It is therefore likely that the immediate
energy requirements of synaptic activity are met by the oxidation
of lactate present in the extracellular space, and that the ANLS
mechanism provides an efficient and spatiotemporally precise
way to replenish the extracellular lactate pool in register with
synaptic activity.
The respective phenotypic features of astrocytes and neurons
that underlie the metabolic interactions that have been reviewed
thus far are subject to developmental regulation and plasticity.
For example, the different molecular determinants that confer
to astrocytes the ability to upregulate aerobic glycolysis in
response to glutamate—namely the glutamate transporter
GLAST, the a2 subunit of the Na+/K+ ATPase, and MCT1—are
upregulated as astrocytes differentiate and acquire the capacity
to increase aerobic glycolysis in response to glutamate (Brunet
et al., 2004). Similarly, in the presence of neurons, astrocytes in-
crease the expression levels of mRNA and proteins for enzymes
critical for glycolysis (phosphofructokinase, aldolase, and pyru-
vate kinase), glycogen metabolism (glycogen synthase and
glycogen phosphorylase), and glutamine synthetase (Mamczur
et al., 2015). This upregulation in astrocytes is paralleled by asimultaneous decrease in the capacity of neurons to metabolize
glucose and glutamine.
In summary, these observations indicate that, in the brain,
glycolysis is concentrated in astrocytes to sustain, via lactate
export, neuronal energy needs in register with activation. As
nicely formulated by Barros, glycolysis is ‘‘outsourced’’ by neu-
rons to astrocytes (Barros, 2013).
Other intercellular signals in addition to glutamate promote
aerobic glycolysis in astrocytes, such as arachidonic acid,
noradrenaline, and potassium (Bittner et al., 2011; Hutchinson
et al., 2007; Obel et al., 2012; Ruminot et al., 2011; Takahashi
et al., 1995; Yu et al., 1993). In particular, through elegant studies
using high-temporal-resolution Fo¨rster resonance energy trans-
fer (FRET) glucose nanosensors, Barros and colleagues showed
that concentrations of K+ reached in the extracellular space dur-
ing neuronal activity stimulate a rapid (within seconds) increase
in the glycolytic rate of astrocytes, both in cultures and slices
(Bittner et al., 2011). There appears to be a temporal comple-
mentarity between the K+- and glutamate-evoked aerobic
glycolysis in astrocytes, the former affording a rapid and tran-
sient processing of glucose whereas the latter is delayed and
sustained (Bittner et al., 2011). The glycolytic action of K+ in
astrocytes involves the mobilization of the Na+/HCO3
 cotrans-
porter NBCe1 (Ruminot et al., 2011; as later confirmed by Choi
et al., 2012).
Another mechanism of neuron-glia metabolic coupling in-
volves the mobilization of glycogen, the storage form of glucose
exclusively localized in astrocytes. A restricted set of neurotrans-
mitters is able to promote glycogenolysis in astrocytes, the main
ones being vasoactive intestinal peptide (VIP) and noradrenaline
(NA) (Magistretti et al., 1981). The intracellular signaling mecha-
nism triggered by VIP and NA to promote glycogenolysis is the
adenylate-cyclase cascade. Glycogenolysis is also promoted
by certain neuromodulators such as the purinergic agonists
adenosine and ATP (Sorg et al., 1995; Sorg and Magistretti,
1991) as well as by activity-dependent increases in extracellular
K+ (Hof et al., 1988). The morphology of the neuronal circuits
that contain VIP and NA in the neocortex is of particular interest
in relation to energy metabolism regulation. Indeed, VIP neurons
represent a homogeneouspopulation of bipolar cells that arepre-
sent throughout the neocortex. Like most cortical interneurons,
they receive thalamocortical andcorticocortical afferents (Magis-
tretti andMorrison, 1988);whatmakes themparticular is that their
radially oriented dendritic arbor spans across virtually all cortical
layers, implying that the VIP neurons are in a position to translate
the afferent volley to the neocortex into a metabolic message to
astrocytes by mobilizing energy reserves from glycogen within
radially restricted volumes corresponding to functional columns.
In contrast, the noradrenergic fibers, which all originate in the
locus coeruleus in the brainstem, span the entire cortical volume
horizontally from the frontal to the occipital poles, meaning that
when activated, they mobilize glycogen globally throughout the
cortical mantle and across functionally distinct areas, resulting
in an energetic priming state of the neocortex (Figure 4).
In summary, at least two main mechanisms exist for coupling
neuronal activity to energy delivery by astrocytes: aerobic glycol-
ysis triggered by glutamate and a few other signals including K+,
and VIP/NA-stimulated glycogenolysis. Both processes lead toNeuron 86, May 20, 2015 ª2015 Elsevier Inc. 891
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2013; Magistretti, 2006).
An additional spatiotemporal dimension of neuron-glia meta-
bolic coupling in brain energy metabolism to be considered is
the role of the gap-junctional communication that astrocytes
entertain with other astrocytes and with oligodendrocytes
(Fu¨nfschilling et al., 2012; Giaume et al., 2010, 2013). Through
gap junctions, metabolites can be distributed at distances
throughout the glial syncytium. For example, in the hippocam-
pus, glucose delivery by a patch pipette to a single astrocyte
can sustain neuronal activity at distances (Rouach et al., 2008).
This effect is mimicked by lactate and is abolished in the
presence of the MCT inhibitor a-cyano-4-hydroxycinnamic
acid, suggesting that glucose present in the astrocytic network
is metabolized to lactate, transported through the astrocytic syn-
cytium, and used by neurons to sustain their synaptic activity
(Rouach et al., 2008). Astrocytic metabolic waves, analogous
to the well-characterized calcium waves, have been described
using a fluorescent analog of glucose (Bernardinelli et al.,
2004). A similar intercellular trafficking of lactate across gap
junctions necessary for axonal function has been shown to occur
between astrocytes and oligodendrocytes (Fu¨nfschilling et al.,
2012; Saab et al., 2013).
As part of a discussion on the role of neuron-glia interactions in
brain energy metabolism, one should mention the existence of
mechanisms that regulate the local delivery of energy substrates
to the active neuropil through the local regulation of blood flow.
Since the formulation of the hypothesis by Roy and Sherrington
that a coupling existed between the local vascular supply and
functional activity, the search for the identification of ‘‘chemical
products,’’ as stated by the authors (Roy and Sherrington,
1890), that would mediate such coupling has been ongoing.
For extensive treatment of the subject, readers are referred to
recent reviews (see, e.g., Attwell et al., 2010; Cauli and Hamel,
2010; Filosa and Iddings, 2013; Hillman, 2014; Kleinfeld et al.,
2011; Petzold and Murthy, 2011).
5. The Emerging Role of Lactate in Neuroenergetics
Glucose is the main energy substrate for the adult brain under
physiological conditions. However, as noted earlier, evidence
now shows that the three-carbonmonocarboxylate lactate plays
an important role in neuroenergetics. Following the original
observation by Henry McIlwain in the 1950s in brain slices
(McIlwain, 1953), evidence accrued from both in vitro and in vivo
studies over the past two decades indicates that lactate is also
an efficient energy substrate capable of sustaining neuronal
activity (Boumezbeur et al., 2010; Bouzier et al., 2000; Bouzier-
Sore et al., 2006; Itoh et al., 2003; Qu et al., 2000; Schurr et al.,
1997; Schurr and Gozal, 2011; Serres et al., 2005; also reviewed
in Be´langer et al., 2011a; Pellerin et al., 2007; Pellerin and Mag-
istretti, 2012).
With a plasma level of approximately 1.0 mM, lactate crossing
the blood-brain barrier via MCT1 (Pierre and Pellerin, 2005) is
fully oxidized and can provide up to 8%–10% of the brain’s en-
ergy requirements (Boumezbeur et al., 2010; Gallagher et al.,
2009; Smith et al., 2003; van Hall et al., 2009). This contribution
may be even greater at supraphysiological lactate concentra-
tions (i.e., following intravenous lactate infusion), with a near-892 Neuron 86, May 20, 2015 ª2015 Elsevier Inc.linear relationship (Boumezbeur et al., 2010; van Hall et al.,
2009). During moderate-to-vigorous exercise, resulting in blood
lactate concentrations of up to 10 mM, the human brain takes up
and oxidizes lactate to a considerably larger extent than under
normal conditions, supplying up to 20%–25% of total brain
energy demands; this increase in lactate oxidation occurs at
the expense of blood glucose utilization (van Hall et al., 2009).
Overall, these data demonstrate that plasma lactate can be an
efficient energy substrate for the adult human brain. In addition,
if formedwithin the brain parenchyma via the ANLS from glucose
that has crossed the blood-brain barrier or from astrocytic
glycogen, lactate may in fact become the preferred energy
substrate for activated neurons.
Quantitative studies in primary cultures have shown that
neuronal oxidative metabolism is largely supported by lactate
even in the presence of equicaloric amounts of glucose (Bouz-
ier-Sore et al., 2003, 2006; Itoh et al., 2003). In rat cerebral cortex
using [1-11C]L-lactate and [18F]fluorodeoxyglucose as sub-
strates, it was shown that in vivo, lactate is readily oxidized in
an activity-dependent manner; furthermore, increasing plasma
lactate results in the reduction of cerebral glucose utilization
(Smith et al., 2003; Wyss et al., 2011). In line with the latter obser-
vations, NMR studies using [3-13C]lactate in vivo in humans
(reviewed in Bouzier-Sore and Pellerin, 2013) indicate that
lactate is metabolized in a predominantly neuronal compartment
(Boumezbeur et al., 2010). This in vivo lactate use by the brain is
in fact correlated with the level of neuronal activity (Serres et al.,
2004). For example, during whisker stimulation in rats, an in-
crease in lactate produced from plasma 13C-labeled glucose
occurs in the corresponding somatosensory cortex (Sampol
et al., 2013).
Such glucose-derived lactate use by neurons had also been
demonstrated by Tsacopoulos and colleagues in the well-com-
partmentalized guinea pig retina containing photoreceptors
attached to Mueller cells (glia); they showed that lactate, formed
glycolytically from glucose, is released by Mueller cells to fuel
activated photoreceptors (reviewed in Tsacopoulos and Magis-
tretti, 1996).
Consistent with its role as a neuronal energy substrate, lactate
exerts a neuroprotective role when the energy supply is defec-
tive. In slices, lactate can preserve neuronal integrity and func-
tion during glucose depletion (Berthet et al., 2009; Izumi et al.,
1994, 1997; Schurr et al., 1988) or under posthypoxic conditions
(Schurr et al., 1997). In vivo, blockade of lactate transport exac-
erbates delayed neuronal damage in a rat model of cerebral
ischemia (Schurr et al., 2001) whereas, as a mirror effect, direct
intracerebroventricular or intravenous administration of lactate
protects the mouse brain against ischemic damage (Berthet
et al., 2009, 2012). In line with this, exogenous supplementation
of lactate shows promising perspectives for intervention in hu-
mans with traumatic brain injuries (Bouzat et al., 2014; Bouzat
and Oddo, 2014). Brown and collaborators have shown that
axonal function is preserved under aglycemic conditions through
a mechanism involving mobilization of astrocytic glycogen and
the associated lactate transfer to axons (Brown et al., 2005;
Evans et al., 2013; Tekko¨k et al., 2005). Consistent with these ob-
servations, strategies aiming at increasing glycogen levels in as-
trocytes have been successfully used to mitigate neuronal loss
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et al., 2007; Swanson and Choi, 1993). Enhancing astrocyte-
neuron lactate shuttling through the overexpression of the
glucose transporter GLUT1 in astrocytes and MCT2 in neurons
in a coculture model was shown to be neuroprotective against
excitotoxic insults (Bliss et al., 2004). Thus, boosting lactate
transfer from astrocytes to neurons may represent an effective
neuroprotective therapeutic strategy not only under glucose-
deprivation conditions but more generally against neuronal
insults associated with intracellular energy deficiency such
as excitotoxicity. In contrast, conditions under which lactate
delivery to neurons is impaired lead to neuronal damage. For
example, disruption of MCT1 expression in oligodendroglia
(which are coupled to astrocytes through gap junctions), result-
ing in an impairment in the delivery of lactate, produces axonal
damage and neuronal loss in animal and cell-culture models
(Fu¨nfschilling et al., 2012; Lee et al., 2012), an observation that
may be relevant to the pathophysiology of amyotrophic lateral
sclerosis (Lee et al., 2012).
In addition to its role as an energy substrate, lactate has also
recently been shown to exert intercellular signaling functions
(for a review, see Barros, 2013; Bergersen and Gjedde, 2012).
Lactate activates glucose-sensing and orexin neurons in the
hypothalamus as well as GABAergic neurons in the subfornical
organ (see Be´langer et al., 2011a, and references therein).
Although the mechanism(s) of action of lactate in this instance
is not entirely characterized, it appears to critically involve
ATP-sensitive K+ channels (KATP) (see Be´langer et al., 2011a,
and references therein). Increased ATP concentration, produced
by lactate oxidation, triggers the closure of KATP channels,
leading to membrane depolarization and neuronal activation,
providing a mechanism that links lactate release by astrocytes,
lactate utilization by neurons, and modulation of neuronal
excitability. These observations add another level of interaction
between astrocytes and neurons with regard to energy meta-
bolism. Other regulatory processes of neuronal excitability by
lactate shuttling between astrocytes and neurons may also
operate (Bozzo et al., 2013; Erlichman et al., 2008; Nagase
et al., 2014; Tang et al., 2014; Yang et al., 2014). For example,
a pH-dependent effect of lactate has been reported to modulate
the activity of the chemosensory (pH-dependent) neurons of
the retrotrapezoid nucleus in the ventral medulla, which controls
breathing rate (Erlichman et al., 2008). Binding of lactate to
the GPR81 receptor (Bozzo et al., 2013) or potentiation of
the NMDA receptor through lactate-induced red-ox changes
(NAD/NADH ratio) (Yang et al., 2014) has been associated with
modulation of neuronal activity.
Of importance regarding higher brain functions, astrocyte-
derived lactate is required for learning and memory processes.
Suzuki et al. (2011) have demonstrated that the transfer of
glycogen-derived lactate from astrocytes to neurons is required
for long-term memory formation and for the in vivo maintenance
of long-term potentiation. Intrahippocampal injection of DAB (a
potent inhibitor of glycogen phosphorylase and hence of lactate
production from glycogen) specifically impaired long-term
memory formation (while leaving short-term memory unaf-
fected) in an inhibitory avoidance test in rats. A similar result
was obtained by disrupting the expression of the astrocyte-specific lactate transporter MCT4. These memory-inhibiting ef-
fects were fully rescued by intrahippocampal administration of
lactate but not by equicaloric glucose. Disruption of the expres-
sion of the neuron-specific lactate transporter MCT2 also leads
to amnesia, which, however, is not rescued by exogenous
lactate, indicating that the import of lactate into neurons is
necessary for long-term memory formation. In keeping with
the behavioral effects observed, the in vivo induction of long-
term potentiation and of genes known to be required for mem-
ory formation, such as phospho-CREB, Arc, and phospho-cofi-
lin, was prevented by inhibition of glycogenolysis and MCT4
expression in a lactate-reversible manner (Suzuki et al., 2011).
These data provide in vivo evidence of the existence of an
astrocyte-neuron lactate transfer for physiological functions
such as plasticity and memory (Suzuki et al., 2011). Similar re-
sults have been obtained in a different (working memory)
learning paradigm (Newman et al., 2011). Following up on these
observations on the role of lactate in memory, Yang et al.
showed that lactate, but not glucose, stimulates the expression
of plasticity-related genes such as Arc, Zif268, or brain-derived
neurotrophic factor through a mechanism involving potentiation
of NMDA receptor activity (Yang et al., 2014), providing a likely
molecular mechanism accounting for the effect of lactate in
long-term memory.
6. Contribution of Astrocytes to Producing the Signals
Detected by Functional Brain Imaging Techniques
PET detects metabolic or vascular signals, glucose utilization,
blood flow, and oxygen consumption, and fMRI detects oxy/
deoxyhemoglobin ratios (BOLD) and hemodynamic changes.
These signals are produced by the coupling between neuronal
activity and the vascular and metabolic responses reviewed
above. In other words, these imaging signals are surrogate
markers of neuronal activity. It is therefore critical to under-
stand the relationship between neuronal activity and these
markers. Given the critical role that astrocytes play in the
coupling of neuronal activity with metabolic and vascular re-
sponses, it follows that the role of astrocytes in producing func-
tional brain imaging signals deserves close attention (Figley and
Stroman, 2011; Magistretti, 2000; Magistretti and Pellerin,
1999).
Functional brain imaging techniques are used to monitor brain
activity under both basal and task-evoked conditions. In the
latter, the increased region-specific signal is taken to reflect local
increases in neuronal activity. Electrophysiological measure-
ments made in parallel to hemodynamic signals detected by
fMRI have led to the conclusion that the imaging signals are
closely associated with afferent inputs and local processing as
detected by LFPs rather than with single- or multiunit recordings
produced by output spiking activity (Logothetis et al., 2001;
Raichle and Mintun, 2006). Activity at synapses resulting from
integration of afferent inputs thus appears to be the cellular
site where the signals detected by fMRI are generated. As noted
earlier, a similar localization has been shown for imaging of
glucose utilization with the 2-DG technique (Kadekaro et al.,
1985). This conclusion is substantiated by the analysis of energy
costs associated with neuronal activity, which has clearly identi-
fied synaptic signaling as the main site for energy utilization,Neuron 86, May 20, 2015 ª2015 Elsevier Inc. 893
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cent observation adding to this view shows that postsynaptic
potentials contribute to the energy expenditure associated with
synaptic signaling, as do presynaptic processes, particularly
the filling of synaptic vesicles with neurotransmitters (Rangaraju
et al., 2014).
Synapses are largely ensheathed by astrocyte processes
that can detect synaptically released neurotransmitters, in par-
ticular glutamate, through receptors and reuptake sites. Electro-
chemical and magnetic resonance spectroscopy studies have
unequivocally demonstrated increases in glutamate levels asso-
ciated with modality-specific increases in inputs to a given re-
gion (Hu et al., 1994; Just et al., 2013; Miele et al., 1996; Schaller
et al., 2013). This is not surprising, as about 80% of synaptic in-
puts to a given cortical region are glutamatergic. As reviewed in
the preceding sections, several of themolecular steps have been
described indicating how glutamate implements neurometabolic
coupling by acting on astrocytes. This set of mechanisms
provides a parsimonious and highly efficient mechanism to
ensure energy delivery when and where needed, because the
predominant signal of increased synaptic activity, and hence
increased local energy demands, is glutamate (Magistretti and
Pellerin, 1999). As a corollary of this phenomenology, it follows
that functional brain imaging signals not only depend on neu-
ronal function but also on a proper sequence of signaling cas-
cades that takes place in astrocytes. Thus, alterations of such
imaging signals observed in pathological states should be un-
derstood as reflecting abnormal processes occurring in neurons
as well as in astrocytes.
The physiological mechanisms underlying one of the compo-
nents of the fMRI signal, namely BOLD signal, deserve some
particular consideration, as they are highly relevant to this
discourse. Observations made in the late 1980s by Fox and
Raichle (Fox et al., 1988; Fox and Raichle, 1986) and more
recently further validated with higher-resolution technologies
by Lin et al. (2010) have established that during activation a
certain degree of metabolic ‘‘uncoupling’’ occurs, whereby the
activity-dependent local increases in CBF and glucose utilization
(cerebral metabolic rate of glucose; CMRGlu) are not matched
by commensurate increases in oxygen consumption (cerebral
metabolic rate of oxygen; CMRO2) (Buxton, 2010; Lin et al.,
2010). This occurrence predicts that in the activated region,
the capillaries on the venous side should be enriched in oxyhe-
moglobin, as the excess oxygen carried by the increased blood
flow is not being consumed (Figure 5). This in turn results in
decreased relative levels of deoxyhemoglobin. Consideration
of these physiological phenomena and of the biophysical prop-
erties of the two main forms of hemoglobin led Seiji Ogawa to
develop the now popular BOLD fMRI technique (Ogawa et al.,
1990a, 1990b). Indeed, because of the differential magnetic
properties between oxy- (diamagnetic) and deoxy- (paramag-
netic) hemoglobin, the magnetic susceptibility detected by MRI
is modified, producing a signal specific for the activated region
(Figure 5).
As previously discussed (Magistretti, 2000; Magistretti and
Pellerin, 1999), the glutamate-stimulated aerobic glycolysis as
formulated by the ANLS mechanism provides a metabolic
context with cellular resolution for the origin of the BOLD signal.894 Neuron 86, May 20, 2015 ª2015 Elsevier Inc.Transport into astrocytes of synaptically released glutamate pro-
motes glucose uptake with spatiotemporal precision into the
brain parenchyma; impairment of such glutamate transport into
astrocytes abolishes the activity-evoked increase in the 2-DG
signal (Cholet et al., 2001; Voutsinos-Porche et al., 2003a,
2003b). Glucose is processed through aerobic glycolysis in
astrocytes, implying that pyruvate formed through the glycolytic
pathway is converted to lactate rather than entering the TCA
cycle and the subsequent oxygen-consuming process of oxida-
tive phosphorylation. The occurrence of this metabolic process
is substantiated by the elevated lactate levels detected bymicro-
sensors and microdialysis in rodents and by MRS in humans
in the activated area (Hu and Wilson, 1997; Just et al., 2013;
Prichard et al., 1991; Sappey-Marinier et al., 1992; Schaller
et al., 2013; Suzuki et al., 2011). The occurrence of this glycolytic
step in astrocytes also implies that during the activation, oxygen
consumption will not increase, in accordance with observed
increases in oxyhemoglobin in the activated region. Given the
oxidative nature of neurons, the released lactate will be oxidized,
resulting in a delayed increase in oxygen consumption.
BOLD fMRI studies have also reported the occurrence of an
initial dip, or negative BOLD signal, in the very early stages of
activation. This is consistent with the occurrence of an early
oxidative use of lactate followed by delayed production of lactate
that transiently exceeds consumption.
Consistent with this observation, analysis of lactate transients
indicates an initial lactate dip followed by a delayed decay
(Hu and Wilson, 1997; Mangia et al., 2003) (Figure 5). Such a
sequence of events has been supported by two-photon imaging
analyses of NADH in hippocampal slices. Activation of the intra-
hippocampal Schaffer collateral pathway induces a biphasic
NADH fluorescence response consisting of a rapid and transient
decrease of NADH levels, reaching a minimum (dip) 10 s after
stimulation, followed by a sustained overshoot of NADH,
peaking at 60 s (Kasischke et al., 2004). Decreases in NADH fluo-
rescence reflect a rapid and transient activation of oxidative
metabolism, whereas a delayed sustained increased NADH
fluorescence reflects the activation of their glycolytic rate
(Kasischke et al., 2004). Interestingly, the temporal sequence
of these cell-specific NADH transients closely parallels the extra-
cellular temporal sequence of the lactate transients observed
in vivo in human and rodent brains, characterized by an early
decrease (Hu and Wilson, 1997; Mangia et al., 2003) followed
by a sustained increase (Hu and Wilson, 1997; Lin et al., 2010;
Prichard et al., 1991) (Figure 5).
In summary, glutamate released by synaptic activity produces
excitatory postsynaptic potentials (EPSPs) in target neurons
(Figure 5, inset 1,N) and is avidly taken upby astrocytes (Figure 5,
inset 1, A). The immediate energy needs of activated neurons are
met by oxidation of lactate present in the extracellular space,
resulting in a transient decrease in lactate levels and oxygen con-
centration (Figure 5, inset 2). The decreased deoxyhemoglobin
levels produce the initial dip of the BOLD signal (Figure 5, inset
4). The occurrence of a delayed transient aerobic glycolysis in
astrocytes resulting in increased glucose uptake and lactate
production as described by the ANLS provides a temporal win-
dow during which oxygen is not consumed commensurately
with glucose metabolism (Figure 5, inset 3), providing a transient
Neuron
Reviewrelative decrease in deoxyhemoglobin (due to the increased
oxyhemoglobin concentration) that results in positive BOLD
signal (Figure 5, inset 4). An additional intriguing link between
increases in lactate during activation and the BOLD signal
have been provided by von Pfo¨stl et al. (2012), by showing that
increases in plasma lactate concentrations dose-dependently
produce a BOLD signal detected by fMRI in nonhuman primates
(von Pfo¨stl et al., 2012).
7. Evolutionary Considerations
Energy utilization by the brain markedly varies across spe-
cies (Herculano-Houzel, 2011). Thus, glucose utilization in-
creases from 0.3–1.2 mmol/min in rodents (rats and mice), to
30–60 mmol/min in nonhuman primates, to 450 mmol/min in hu-
mans. Interestingly, the percentage of energy resources allo-
cated to the brain also similarly varies, with 2% of whole-body
energy consumption being used to meet the energy demands
of the rodent brain, 9%–12% for nonhuman primates, and
20% for humans (Mink et al., 1981). This increase in relative en-
ergy utilization by the brain is actually greater than that predicted
by the increase in body size (Karbowski, 2007; Martin, 1981). In
addition to brain size, a massive, nonlinear development in
neocortex size has occurred in humans, which accounts for
over 40% of whole-brain energy utilization (Lennie, 2003).
There is ample evidence indicating that the distinctive appear-
ance of higher cognitive functions in humans when compared to
other nonhuman primate species (Tomasello and Call, 1997) is
largely related to the massive expansion of the neocortex (Jeri-
son, 1973; Stephan et al., 1988), suggesting that the emergence
of higher cognitive functions in humans is closely associatedwith
a considerable increase of energy consumption devoted to
neural processing (Aiello and Wheeler, 1995; Goodman and
Sterner, 2010). Another element associated with the expansion
of the human brain and in particular of the neocortex is the large
increase in the number of neurons in this brain area over the
course of evolution. Comparatively, rodents have 10–31 million
neurons, nonhuman primates 1.7–5.5 billion, and humans 16
billion (Herculano-Houzel, 2011). Not only does the number of
neurons in the neocortex increase but the complexity of their
dendritic arborization—the number of spines and synapses—
increases more than linearly in humans. These facts bear at least
two implications: first, because of the massive neuronal arbori-
zation increase, the density of neurons per unit volume is likely
to be lower in humans. Consistent with this fact, the energy uti-
lization (i.e., glucose use) per unit volume is considerably lower
in humans compared with non/human primates and rodents
with, for example, 0.89 and 0.68 mmol/g,min in mouse and rat,
respectively, 0.44 mmol/g,min in baboons, and 0.31 mmol/g,min
in humans (Herculano-Houzel, 2011). A question that is still
debated is the energy consumption per neuron: is it constant
across species, or do neurons with larger arborizations consume
more energy? According to the former view, brain size is essen-
tially determined by the number of neurons and the increase in
energy utilization with increasing brain size in a simple linear rela-
tionship with neuron number (Herculano-Houzel, 2011). Another
view attributes the increase in energy utilization by larger brains
not only to the sheer number of neurons but also to their larger
dendritic arborization in more evolved brains (Sherwood et al.,2006). Notwithstanding this debate, the evidence gathered so
far does point to a relative constancy of energy requirements
per neuron across species, compounded, however, by the de-
mands that are imposed formaintaining resting potentials across
a large dendritic spatial expanse. In particular, the high density of
synaptic contacts on dendritic spines in humans resulting, upon
activation, in electrochemical ion-gradient disruption imposes
even higher energy demands (Elston et al., 2006; Friede and
van Houten, 1962; Harrison et al., 2002).
Given the existence of a tight metabolic coupling between
neurons and glia, astrocytes in particular, consideration of the
contribution of this cell type to brain energy metabolism evolu-
tion is warranted. The glia/neuron ratio increases across evolu-
tion, with a 1.6 ratio in the human neocortex (Sherwood et al.,
2006). The increase is only slightly above what should be ex-
pected from an allometric increase; the fact remains, however,
that there are more astrocytes, the predominant sites of glucose
uptake, in the human cortex than in lower species. Furthermore,
there is evidence that each human neocortical neuron consumes
close to three times more ATP per neuron both to maintain
resting membrane potential and to fire (Lennie, 2003). Given
the critical role that astrocytes play in sustaining the energetic
requirements of neurons, it is not surprising that the overall astro-
cyte/neuron ratio has increased in humans.
Gene profiling techniques have provided a powerful tool to
identify enrichments in the expression of certain genes that are
correlated with higher cognitive functions when comparing
human with nonhuman primates. Interestingly, the picture that
emerges is that there is a massive increase in the expression
of genes involved in energy production in the human neocortex
(Ca´ceres et al., 2003; Uddin et al., 2004), particularly those
involved in the electron chain transfer of ATP-producing oxida-
tive phosphorylation (Grossman et al., 2004; Khaitovich et al.,
2006). These observations indicate that throughout evolution,
the human neocortex, which is so intimately related to the higher
functional abilities that characterize humans, has evolved toward
an energy-producing profile, which favors the oxidative produc-
tion of ATP. This is a highly energy-efficient metabolic pathway
that, however, bears the intrinsic risk of producing more poten-
tially damageable reactive oxygen species. Metabolomic anal-
ysis likewise indicates an over 4-fold increase in metabolic
changes that are specific to the human prefrontal cortex
compared with nonhuman primate species (Fu et al., 2011).
Furthermore, studies across organs and species show an accel-
eration of metabolome evolution in the human prefrontal cortex
and skeletal muscle compared to nonprimate species in a way
that indicates, in humans, a preferential allocation of energy
production to the brain compared to muscle (Bozek et al.,
2014). It also appears that brain energy metabolism is inversely
correlated during development, suggesting that the high meta-
bolic cost of brain function is compensated by a slowing of the
body growth rate (Kuzawa et al., 2014).
Cross-species comparisons of the level of expression of the
isoforms of lactate dehydrogenase (LDH) indicate that, in the
human neocortex, the metabolic substrate for feeding the tricar-
boxylic acid cycle and eventually the electron transport chain is
lactate (Duka et al., 2014). LDH is a tetrameric enzyme formed by
various combinations of two units, A and B, which are encodedNeuron 86, May 20, 2015 ª2015 Elsevier Inc. 895
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Reviewby two distinct genes. The one with predominantly A subunits
(LDHA) provides high throughput for lactate production, and is
accordingly the predominant form found in lactate-producing
cells such as skeletal myocytes. In contrast, the LDHB form is
expressed in cells that take up lactate and metabolize it to pyru-
vate to produce energy, such as cardiac myocytes. In the rodent
brain, neurons selectively express the LDHB form, whereas the
LDHA form is almost exclusively found in astrocytes (Bittar
et al., 1996). Western blot analyses of the expression of the
LDH isoforms indicate that the synaptosomal fraction of the
human neocortex contains predominantly the LDHB form,
consistent with a predominant use of lactate as a substrate for
energy production by neurons (Duka et al., 2014).
8. Conclusions
Considerable progress has been made over the last two de-
cades in understanding the cellular, and in some cases mo-
lecular, mechanisms of brain energy metabolism. The main
realization is that, not surprisingly, different cell types have
distinct metabolic profiles, with a particular distinction between
neurons and astrocytes. This relative cell specificity of energy
metabolism implies the existence of rich and coordinated cell-
cell signaling mechanisms in the regulation of metabolic pro-
cesses. Novel techniques, with even higher spatial and temporal
resolution, will provide new tools to refine our understanding of
intercellular metabolic exchanges and possibly reveal a higher
level of regulation in subcellular compartments. From a more
global perspective, functional brain imaging techniques, which
have also blossomed over the last two decades, along withmag-
netic resonance spectroscopy investigations have provided new
insights into brain energy metabolism. Indeed, although such
techniques bymonitoring metabolic processes provide amarker
of neuronal activity, they also have revealed some unexpected
characteristics of brain metabolism such as the uncoupling
between glucose utilization and oxygen consumption along
with the enrichment in oxyhemoglobin in activated areas. It is
therefore of great importance to bridge the gap in resolution
scales between the cellular and molecular techniques with
those, such as imaging techniques, that monitor metabolism at
the local, multicellular, and circuit level. This is certainly a chal-
lenge that is worth pursuing, to better understand both the
fundamental physiological phenomena of brain function as well
as the significance of alterations in functional brain imaging
signals that are detected in several neuropsychiatric disorders.
Furthermore, as reviewed in the preceding section, an associa-
tion exists between the emergence of higher cognitive functions
in humans and a considerable expansion of the neocortex
accompanied by an increase in glucose utilization and the
expression of energy metabolism genes. If nothing else, such
associations warrant a sustained effort to understand better
the cellular and molecular determinants of neuroenergetics,
with particular attention to the human brain.
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